SlidesetHIVRaltegravir (RAL) pharmacokinetics (PK) and safety in HIV-1-exposed neonates at high risk of infection (IMPAACT 1110) | Dr. D. ClarkeView Slideset
SlidesetHIVHIV PCR testing at birth in KwaZulu Natal, South Africa – one year post introduction of the largest neonatal HIV testing programme | Dr. F. MoyoView Slideset
SlidesetHIVSwitching to second-line antiretroviral therapy in HIV-infected children: a CIPHER cohort collaboration global analysis | Dr. R. GoodallView Slideset
SlidesetHIVPaediatric HIV point of care testing: field evaluation of the performance of Cepheid and Alere qualitative HIV assays in a Soweto academic hospital | Dr. T. MurrayView Slideset
SlidesetHIVLow-Resource Perspective on Adolescent Transition and Research Priorities | Mary-Ann Davies, MBChB, MMed, PhD, FCView Slideset
SlidesetHIVThe global epidemiology of perinatally HIV-infected adolescents: A CIPHER Global Cohort Collaboration analysis | Dr. Amy SlogroveView Slideset
SlidesetHIVIt’s Not Just HIV: Complications and Research Priorities in Care of HIV-Infected Youth | Rashida Ferrand, MBBS, MRCP, MSc, DRM&HView Slideset
SlidesetHIVHigher retention and viral suppression rates in dedicated adolescent-friendly HIV clinic in South Africa | Brian Zanoni, MD, MPHView Slideset
SlidesetHIVHigh-Resource Perspective on Adolescent Transition and Research Priorities | Ali JuddView Slideset
SlidesetHIVDecreased bone turnover in HIV-infected children on antiretroviral therapy | Dr. S. ShiauView Slideset
SlidesetHIVDoes HIV DNA-PCR testing of HIV-exposed infants at birth reduce follow-up for routine testing at 4-14 weeks of age? | Dr. E. KalkView Slideset
SlidesetHIVImpact of birth HIV PCR testing on routine 6-week EID testing in Cape Town, South Africa | Dr. L. DunningView Slideset
SlidesetHIVWhere have all the children gone? High HIV prevalence in infants attending nutrition and inpatient wards | Dr. C. KiyagaView Slideset
SlidesetHIVOutcomes of HIV-exposed infants before and after implementing Option B+ PMTCT guidelines in Kampala, Uganda: a retrospective cohort study | Dr. P. ElyanuView Slideset
SlidesetHIVImpact of tenofovir-containing triple antiretroviral therapy (ART) on bone mineral density in HIV-infected breastfeeding women in sub-Saharan Africa | Dr. L. StranixView Slideset
SlidesetHIVThe Challenge of Drug-Resistant TB in Children with HIV | Simon Schaaf, MMed, PhDView Slideset
SlidesetHIVLung function in HIV-infected South African adolesents on antiretroviral therapy: the Cape Town adolescent antiretroviral cohort | Dr. L. GithinjiView Slideset
SlidesetHIVNeuropsychological performance in African HIV children in a multi-site ARV clinical trial is poorer than non-infected children | Dr. M. BoivinView Slideset
SlidesetHIVPediatric HIV Treatment and Prevention: From Then to Now | Peter Mugyenyi, MB ChB, FRCPI, FRCPView Slideset
SlidesetHIVPediatric Drug Pipeline: New Drugs, New Strategies | Martina Penazzato, MD, DTMH, MSc, PhDView Slideset
SlidesetHIVVirological response and resistance among HIV-infected children on first-line antiretroviral therapy without routine virological monitoring | Dr. Andrew PrendergastView Slideset
SlidesetHIVAccess to antiretroviral initiation among HIV-infected children aged 0-19 years in the International Epidemiologic Databases to Evaluate AIDS Global Network | Dr. V. LeroyView Slideset
